- Home
- ICON vs GCTK Comparison
ICON vs GCTK Comparison
Compare ICON & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICON | GCTK |
|---|---|---|
| Founded | 2023 | 2001 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3M | 1.6M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICON | GCTK |
|---|---|---|
| Price | $1.44 | $1.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $22.50 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 941.2K |
| Earning Date | 04-02-2026 | 11-13-2025 |
| Dividend Yield | ★ 2901.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,449,000.00 | N/A |
| Revenue This Year | $128.63 | N/A |
| Revenue Next Year | $10.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 96.44 | N/A |
| 52 Week Low | $1.43 | $1.52 |
| 52 Week High | $72.00 | $40.78 |
Technical Indicators
Market Signals| Indicator | ICON | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 42.05 | 23.49 |
| Support Level | $1.43 | $1.52 |
| Resistance Level | $1.80 | $1.89 |
| Average True Range (ATR) | 0.20 | 0.30 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 1.31 | 5.30 |
Price Performance
Historical ComparisonAbout ICON Icon Energy Corp.
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.